CIP‐0003 ALLAY-HF: Safety and Efficacy of the Alleviant System for No-Implant Interatrial Shunt Creation in Patients with Chronic Heart Failure

NCT05685303

ALLAY-HF: Safety and Efficacy of the Alleviant System for No-Implant Interatrial Shunt Creation in Patients with Chronic Heart Failure

Principal Investigator

Sponsor

ALLEVIANT MEDICAL, INC.

To evaluate the safety and efficacy of the Alleviant ALV1 System in
patients with chronic heart failure (HF) and preserved ejection fraction
(HFpEF) or mildly reduced ejection fraction (HFmrEF), who remain
symptomatic despite appropriate guideline directed medical therapy
(GDMT).

This study is currently enrolling.